Unsurprisingly, women with inherited pathogenic mutations in BRCA1 or BRCA2 have up to an 85% risk of breast cancer development; hence, risk reduction measures, such as intensive radiological screening, prophylactic surgery, or chemoprevention were suggested for these candidates (Thompson and Dixon, 1992). This evidence concerns the gene BRCA1 and breast carcinoma.